GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways

Selenium nanoparticles (Se NPs) have attracted increasing interest in recent decades because of their anticancer, immunoregulation, and drug carrier functions. In this study, GE11 peptide-conjugated Se NPs (GE11-Se NPs), a nanosystem targeting EGFR over-expressed cancer cells, were synthesized for o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi, Jiang, Jiang, Jinhuan, Cai, Huaihong, Yang, Fen, Jin, Hua, Yang, Peihui, Cai, Jiye, Chen, Zheng W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920706/
https://www.ncbi.nlm.nih.gov/pubmed/29019267
http://dx.doi.org/10.1080/10717544.2017.1386729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920706/
https://www.ncbi.nlm.nih.gov/pubmed/29019267
http://dx.doi.org/10.1080/10717544.2017.1386729

Ejemplares similares